From Wikipedia, the free encyclopedia
[edit] Merlin / TIMI 36
The TIMI 36 trial is a large trial featuring ranolazine in individuals with NSTEMI. The results of the trial should be available by the end of March, 2007. Ksheka 17:20, 8 February 2007 (UTC)